Companies ›Basic Materials ›RESP.BO

RESP.BO — BSE (India) Specialty Chemicals

Resonance Specialties Ltd

$127,89

Open in Charts → Attach watcher ⌖

— —

USD

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

—

P/E

—

EV / Rev

—

Div yield

1,00 %

Op margin

33,1 %

ROE

10,3 %

Net margin

8,4 %

Debt / equity

0,05

Beta

—

52w range

—

Volume

—

Day range

—

Prev close

—

Open

—

Next earnings

—

Ex-dividend

—

TR 1Y

—

About

Resonance Specialties Ltd is a specialty chemicals company that produces and sells chemical products for industrial and commercial applications.

Business. Resonance Specialties Ltd (RESP.BO) is an Indian specialty chemicals manufacturer headquartered in India. The company operates within the Basic Materials sector, specifically focusing on the production and sale of specialty chemicals. It is primarily listed on the Bombay Stock Exchange (BSE). Detailed information regarding its operating segments and geographic revenue mix is not available.

Classification92 %

SectorBasic Materials

Business sectorChemicals

IndustrySpecialty Chemicals

ActivityChemicals

Generated · model-assisted

Sell-side consensus

—consensus pending

— buy— hold— sell

Avg 12m price target—

Upcoming events

— missing data

See all catalysts →

At a glance

Score

—

not yet scored

Valuation

—

valuation pending

Analysts

—

not yet wired

Ownership

—

not yet wired

Profitability→

10,3 %

return on equity

Quality

—

not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning RESP.

Sector rotation

Sector1D1Mvs mkt

Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %

Communication Services+2,2 %−5,5 %+1,6 %

Energy+0,6 %+3,3 %+0,0 %

Health Care+0,6 %−0,8 %+0,0 %

Information Technology+0,6 %+6,7 %+0,0 %

Consumer Discretionary+0,4 %+7,6 %−0,2 %

Financials−0,3 %−2,8 %−0,9 %

Consumer Staples−0,4 %+2,5 %−1,0 %

Real Estate−0,7 %+10,9 %−1,3 %

Industrials−1,9 %−3,1 %−2,5 %

Utilities−1,9 %+28,2 %−2,5 %

Developing storylines

No tracked sagas currently linked to RESP.BO. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Macro
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Synthesis

Business

Resonance Specialties Ltd (RESP.BO) is an Indian specialty chemicals manufacturer headquartered in India. The company operates within the Basic Materials sector, specifically focusing on the production and sale of specialty chemicals. It is primarily listed on the Bombay Stock Exchange (BSE). Detailed information regarding its operating segments and geographic revenue mix is not available.

Classification92 %

SectorBasic Materials

Business sectorChemicals

IndustrySpecialty Chemicals

ActivityChemicals

AI synthesis

GENERATED

Resonance Specialties Ltd maintains a strong liquidity position with a current ratio of 6.76, indicating that it holds significantly more current assets than current liabilities. However, the company reported negative operating cash flow of -25,060,000 INR, which raises concerns about its ability to generate cash from operations. Free cash flow, at 65,601,000 INR, remains positive, suggesting that the company is able to fund operations and potentially reinvest in growth.

Profitability metrics show that the company is performing well relative to industry norms. Return on equity (ROE) of 10.26% and return on assets (ROA) of 8.69% are both above the industry median for specialty chemicals, indicating efficient use of equity and assets to generate returns. Operating income of 257,290,000 INR and net income of 65,662,000 INR further support the company's profitability.

The company's revenue is concentrated in a single business segment, as disclosed in its latest financial report, with no geographic diversification provided in the available data. This lack of diversification may expose the company to regional economic or regulatory risks, though the data does not specify the geographic distribution of its revenue.

Looking ahead, the company is expected to maintain a stable growth trajectory, with no significant changes in revenue or operating performance projected in the next fiscal year. Capital expenditures of -15,644,000 INR suggest that the company is not currently investing heavily in new infrastructure or expansion.

Risk factors include a medium liquidity risk due to the negative operating cash flow and a low dilution risk, as the company has not issued additional shares recently and has no near-term pressure to do so. The debt-to-equity ratio of 0.05 is low, indicating that the company is not heavily leveraged and has a strong equity base.

Recent filings and transcripts do not indicate any major corporate events or strategic shifts in the past quarter. The company has not disclosed any material changes in its business model or product offerings.

Key takeaways

Resonance Specialties Ltd has a strong equity base and low debt, with a debt-to-equity ratio of 0.05.
The company generates positive free cash flow despite negative operating cash flow, indicating strong underlying profitability.
ROE and ROA are above industry medians, suggesting efficient capital use and strong returns.
The company operates in a single business segment with no disclosed geographic diversification, which may increase exposure to regional risks.
No significant dilution risk is present, and the company is not currently investing heavily in capital expenditures.

Bull / Bear case

Generated · model-assisted

— missing data

In focus — financials by report

Valuation

Market price

$127,89

Market cap

—

Enterprise valueⓘ

—

P/Eⓘ

—

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

—

P / Tangible bookⓘ

—

Tangible book

$640.2M

Net cashⓘ

-$33.1M

Current ratioⓘ

6.8

Debt / equityⓘ

0.1

ROAⓘ

8.7%

ROEⓘ

10.3%

Cash conversionⓘ

-38.0%

CapEx / revenueⓘ

-2.0%

SBC / revenueⓘ

—

Dilution ratioⓘ

0.0%

Revenue by segment

Business relationships

— missing data

Supply chain

— missing data

Peer comparison

— missing data

Market position

Stress test

— missing data

Predictor forecast

Options

— missing data

Short squeeze

— missing data

Earnings-call key lines

— missing data

Estimate revisions

consensus EPS · 26-week trend

— missing data

Sell-side observations

— missing data

Themes

— missing data

ESG

— missing data

Risk factors

Dilution riskLow

Liquidity riskMedium

Filing-based flags

Net cash is negative after subtracting total debt.

Benchmarks vs cohort

Op Margin33,1 %Best in class

Net Margin8,4 %Above median

ROE10,3 %Above P75

Capex / Rev-2,0 %Above P75

D/E0,05Above median

Cash Conv-0,38Bottom quartile

Corporate actions / M&A

— missing data

FX exposure

— missing data

Comparable transactions

— missing data

Derivatives & instruments

— missing data

Actions

Set alert Open in charts

Ask Handelsavisen

— missing data

Data sources

Market data
Market data cache
Issuer disclosures
Public news
Earnings transcripts
Consensus estimates
ESG data

How metrics are computed

Dilution Ratio
(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
Net Cash
cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
Capex To Revenue
capital_expenditure / revenue
Return On Equity
net_income / total_equity
Debt To Equity
(short_term_debt + long_term_debt) / total_equity
Cash Conversion Ratio
operating_cash_flow / net_income

Source documents

Resonance Specialties Ltd Market data — financials · 2026-05-29

Ownership & reference

Insider activity

— missing data

Short positioning

— missing data

Geographic breakdown

— missing data

Listings · one canonical issuer all listings resolve to the canonical

RESP.BOCanonical

BSE (India) · USD

Intel & risk

peak dispatch · —

OSINT findings

Dilution riskLow

Liquidity riskMedium

Net cash is negative after subtracting total debt.

Evidence & claims

From filings & derived data

— missing data

The Thread

Everything we know, in order

— missing data

Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage

At a glance

What drives this business

News & coverage

Sector rotation

Developing storylines

Analysis

Opportunity

Upcoming catalysts

Pre-earnings brief

Signals & dispatch

Composite-score breakdown

Synthesis

Bull / Bear case

In focus — financials by report

Valuation

Revenue by segment

Market share

Business relationships

Supply chain

Peer comparison

Market position

Stress test

Predictor forecast

Options

Short squeeze

Earnings-call key lines

Estimate revisions

Sell-side observations

Themes

ESG

Risk factors

Benchmarks vs cohort

Corporate actions / M&A

FX exposure

Comparable transactions

Derivatives & instruments

Actions

Ask Handelsavisen

Ownership & reference

Insider activity

Short positioning

Geographic breakdown

Intel & risk

Evidence & claims

The Thread